GSK shares dive as weaker vaccine sales unnerve investors
British pharma company one of biggest fallers on FTSE 100 despite better than expected financial results Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker sales of its respiratory syncytial virus (RSV) and shingles vaccines and recently launched medications. Britain’s second-biggest…
Àkótán ìròyìn
British pharma company one of biggest fallers on FTSE 100 despite better than expected financial results Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial results, as investors were unnerved by weaker sales of its respiratory syncytial virus (RSV) and shingles vaccines and recently launched medications. Britain’s second-biggest…
Tẹ̀lé ìròyìn tuntun láti ọ̀dọ̀ àwọn olùtẹ̀jáde tó ṣeé gbẹ́kẹ̀lé pẹ̀lú àkótán kúkúrú. Ṣí ìjápọ̀ orísun àtilẹ̀wá fún àlàyé.